Zymeworks strikes $929 million deal for Theravance Biopharma
Theravance Biopharma Inc
Zymeworks Inc.
Theravance Biopharma Inc TBPH | 0.00 | |
Zymeworks Inc. ZYME | 0.00 |
June 29 (Reuters) - Drugmaker Zymeworks ZYME.O said on Monday it will buy Theravance Biopharma TBPH.O in a $929 million deal.